Azra AI's proprietary software — which uses artificial intelligence (AI) and natural language processing to identify incidental lung nodules in medical reports — is...
Industry leader with substantial U.S. and global experience in drug development and medical affairs joins Lyra as the Company's late-stage product candidates advance in the...
The Company's first product, iCapture™45, is pending FDA clearance. Several clinical trials will commence in the USA and Israel within a few weeks, in addition to an ongoing clinical...
Esco Lifesciences Group ("Esco", the "Company") announces the full acquisition of Evidence Solution ("Evidence"), a Danish software company offering In Vitro Fertilization (IVF) management...
